146 related articles for article (PubMed ID: 6685489)
1. [Comparative antianginal, hemodynamic and pharmacokinetic effects of isosorbide-2-mononitrate and isosorbide dinitrate in the rat].
Leitold M; Laufen H
Arzneimittelforschung; 1983; 33(8):1117-21. PubMed ID: 6685489
[TBL] [Abstract][Full Text] [Related]
2. [Hypotensive, antianginal action and pharmacokinetics of glyceryl-1-nitrate in rats and dogs].
Leitold M; Laufen H; Yeates RA
Arzneimittelforschung; 1986 Nov; 36(11):1577-82. PubMed ID: 3101710
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacokinetics of low-dose isosorbide dinitrate and metabolites after buccal or oral administration].
Keller-Stanislawski B; Marschner JP; Rietbrock N
Arzneimittelforschung; 1992 Jan; 42(1):17-20. PubMed ID: 1586374
[TBL] [Abstract][Full Text] [Related]
4. Nitrate tolerance: hemodynamic effects of intravenous isosorbide dinitrate after sustained oral isosorbide dinitrate administration.
Kumagae H; Koiwaya Y; Tanaka K
Clin Ther; 1990; 12(1):31-43. PubMed ID: 2328526
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic aspects of isosorbide-5-mononitrate in dogs.
Sponer G; Kühnle HF; Strein K; Bartsch W; Endele R; Dietmann K
J Pharmacol Exp Ther; 1984 Jan; 228(1):235-9. PubMed ID: 6694105
[TBL] [Abstract][Full Text] [Related]
6. Comparative hemodynamic study of IS-5-MN and ISDN in man--which are equieffective doses?
Vogt A; Bernhardt S; Schwarck H; Stroh E; Kreuzer H
Z Kardiol; 1983; 72 Suppl 3():182-4. PubMed ID: 6666220
[TBL] [Abstract][Full Text] [Related]
7. Isosorbide dinitrate disposition in the rat: metabolite pharmacokinetics and interactions.
Morrison RA; Fung HL
J Pharmacol Exp Ther; 1984 Oct; 231(1):124-30. PubMed ID: 6491969
[TBL] [Abstract][Full Text] [Related]
8. Oral absorption and disposition of isosorbide dinitrate and isosorbide mononitrates in man.
Laufen H; Aumann M; Leitold M
Arzneimittelforschung; 1983; 33(7):980-4. PubMed ID: 6684933
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the haemodynamic effect of isosorbide-5-mononitrate and isosorbide dinitrate administered in intravenous injection to patients with acute myocardial infarction.
Daskalov TR
Cor Vasa; 1989; 31(5):376-86. PubMed ID: 2612170
[TBL] [Abstract][Full Text] [Related]
10. [The pharmacology and pharmacokinetics of glycerol-2-nitrate].
Leitold M; Laufen H; Yeates RA
Arzneimittelforschung; 1987 Jun; 37(6):692-8. PubMed ID: 3117068
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of isosorbide dinitrate and isosorbide-5-mononitrate.
Schaumann W
Int J Clin Pharmacol Ther Toxicol; 1989 Sep; 27(9):445-53. PubMed ID: 2681004
[TBL] [Abstract][Full Text] [Related]
12. [Hemodynamic effects of a transdermal formulation of isosorbide dinitrate and its pharmacokinetics in conscious dogs].
Kogi K; Tanaka O; Kimura T; Saito T
Nihon Yakurigaku Zasshi; 1982 Oct; 80(4):279-88. PubMed ID: 7152395
[TBL] [Abstract][Full Text] [Related]
13. Hemodynamic effects of isosorbide-5-mononitrate in acute and chronic treatment of coronary heart disease.
Schuster P; Trieb G; Wiechmann HW
Z Kardiol; 1983; 72 Suppl 3():251-4. PubMed ID: 6666229
[TBL] [Abstract][Full Text] [Related]
14. Isosorbide dinitrate bioavailability, kinetics, and metabolism.
Straehl P; Galeazzi RL
Clin Pharmacol Ther; 1985 Aug; 38(2):140-9. PubMed ID: 4017416
[TBL] [Abstract][Full Text] [Related]
15. Hemodynamic effects of oral isosorbide-5-mononitrate and dinitrate in ischemic heart failure.
Rabinowitz B; Hod H; Chouraqui P; Rath S; Agranat O; Neufeld HN
Clin Cardiol; 1987 Oct; 10(10):603-8. PubMed ID: 3665218
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and metabolism of isosorbide-dinitrate after intravenous and oral administration.
Abshagen U; Betzien G; Endele R; Kaufmann B; Neugebauer G
Eur J Clin Pharmacol; 1985; 27(6):637-44. PubMed ID: 3987768
[TBL] [Abstract][Full Text] [Related]
17. [Comparative study of the bioavailability and pharmacokinetics of isosorbide dinitrate formulations in retard form and in standard preparations by determination of isosorbide-5-mononitrate].
Lutz VD; Gielsdorf W; Rasper J; Jaeger H; Loew D
Arzneimittelforschung; 1985; 35(4):730-4. PubMed ID: 4015739
[TBL] [Abstract][Full Text] [Related]
18. Blood and tissue levels of [14C]isosorbide dinitrate after oral and intravenous administration to rat.
Reed DE; Akester JM; Prather JF; Tuckosh JR; McCurdy DH; Yeh C
J Pharmacol Exp Ther; 1977 Jul; 202(1):32-7. PubMed ID: 874817
[TBL] [Abstract][Full Text] [Related]
19. [Bioavailability of isosorbide dinitrate and isosorbide-5-mononitrate under steady-state conditions].
Rietbrock N; Knoll J; Merz PG; Menke G
Dtsch Med Wochenschr; 1985 Nov; 110(47):1821-5. PubMed ID: 3905327
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of the anti-angina effect and effect duration of isosorbide dinitrate, isosorbide-2-mononitrate (IS-2-MN) and isosorbide-5-mononitrate (IS-5-MN)].
Reifart N; Reifart F; Kaltenbach M; Bussmann WD
Med Welt; 1981 Apr; 32(14A):524-6. PubMed ID: 7242313
[No Abstract] [Full Text] [Related]
[Next] [New Search]
